Taysha Gene Therapies Inc Ordinary Shares TSHA
News
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Taysha Gene Therapies Reports Second Quarter 2024 Financial Results and Provides Corporate Update
Taysha Gene Therapies to Release Second Quarter 2024 Financial Results and Host Conference Call and Webcast on August 12
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Taysha Gene Therapies to End Development of TSHA-120 After FDA Feedback
Taysha Gets FDA Fast-Track for Rett Syndrome Treatment